ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database.

Maurizio Sessa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.